Lumin Health provides transformative therapies like ketamine and Spravato for mental health conditions at our Boston-area centers. We accept most major health insurance plans (listed below). Please reach out to explore your options.
Navigating the Cost of Ketamine & Spravato (Esketamine) — A Clear Guide to Insurance and Payment Options
Does insurance cover ketamine therapy or Spravato (esketamine) treatment?
Lumin Health accepts Medicare and most private insurance plans offered in Massachusetts, including Aetna, Anthem, Blue Cross Blue Shield (BCBS), Cigna, Evernorth, Harvard Pilgrim, Optum, Point32Health, Tufts, and United Healthcare.
How Lumin Health Works with your Insurance to Cover Esketamine Therapy
The Lumin Health team is dedicated to making these transformative treatments as accessible as possible. We have extensive experience working with a wide range of insurance providers and would be grateful to champion your case to verify your coverage, explain your benefits in simple terms, and manage the authorization process on your behalf.
The first step is to understand if your insurance plan covers the cost of ketamine. Our team offers a free and confidential insurance verification to determine your plan's benefits for Spravato (esketamine) treatments.
Step 1
Verification of Benefits
Step 2
Prior Authorization
Step 3
Beginning Ketamine Therapy
Major Insurance Providers We Work With at Lumin Health
Frequently Asked Questions about Ketamine Therapy Cost, Insurance Coverage and More
Lumin Health is able to accept most private insurance and Medicare for Spravato (esketamine), which is an FDA-approved version of ketamine. Intravenous ketamine for depression and other forms of ketamine treatment is typically not covered by insurance.
Yes. Most private insurance covers Spravato treatment for people suffering from Treatment Resistant Depression (TRD). Costs are typically a co-pay, and allow for ongoing treatment. Lumin Health accepts Medicare and most private insurance plans offered in Massachusetts, including Aetna, Anthem, Blue Cross Blue Shield (BCBS), Cigna, Evernorth, Harvard Pilgrim, Optum, Point32Health, Tufts, and United Healthcare.
When you reach out to the Lumin Health team, our concierges will offer to pursue coverage information on your behalf. We would be grateful to submit prior authorization requests for you and handle all the paperwork so that you can focus on your treatment and getting better. As a result, Lumin Health will verify coverage for ketamine treatment with Spravato.
Typically, the difference is quite material between IV ketamine infusions and Spravato (esketamine) nasal spray. As Spravato has full FDA-approval to be a monotherapy for treatment-resistant depression, Spravato has full coverage with plenty of commercial insurance plans. Intravenous ketamine or intramuscular ketamine does not have the same approval, so typical plans do not offer coverage. Spravato has shown parallel efficacy to ketamine therapy and offers a robustly effective and much more accessible option for those with a treatment-resistant depression diagnosis.
Typically, ketamine infusions are not covered by Medicare or major private insurance providers. Instead, Spravato (esketamine) is a safe, effective and accessible option with major insurance coverage.
These costs can vary, and we are grateful for the patients that offer this increased level of investment to the treatment. Please get in touch with our team to explore individual options as we do offer sliding scale pricing in the event that cost is a barrier to entry, but typical ketamine infusions at Lumin Health cost around $500 per visit.
The ketamine treatments are covered by neither, but Lumin Health does accept Medicare for Spravato (esketamine) therapy and most other commercial insurance providers.
Before you receive certain medical care, your insurer must agree that the treatment is medically necessary and that it will be covered under your plan. You will need to obtain prior authorization, but Lumin Health would be grateful to secure that for you. Simply get in touch with us to get the process started.
Yes, a particular diagnosis will have an impact on insurance coverage potential. Esketamine treatment and Spravato coverage is contingent on having a diagnosis of treatment-resistant depression. The reality is that each insurance plan has a different definition of what that means – i.e. the specific number of antidepressant trials conducted and failed — so this is why Lumin Health takes such an active role in handling the prior authorization and coverage components.
We do. Get in touch with us to learn more — as each situation is unique and deserves careful consideration.
If you have a Health Savings Account and Flexible Spending Account via credit card, Lumin Health can certainly accept those. You are also welcome to pay out of pocket and request a comprehensive invoice or receipt to try for your own reimbursement.